Your browser doesn't support javascript.
loading
Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.
Ogura, Michinori; Yamamoto, Kazuhito; Morishima, Yasuo; Wakabayashi, Masashi; Tobinai, Kensei; Ando, Kiyoshi; Uike, Naokuni; Kurosawa, Mitsutoshi; Gomyo, Hiroshi; Taniwaki, Masafumi; Nosaka, Kisato; Tsukamoto, Norifumi; Shimoyama, Tatsu; Fukuhara, Noriko; Yakushijin, Yoshihiro; Ohnishi, Kazunori; Miyazaki, Kana; Kameoka, Yoshihiro; Takayama, Nobuyuki; Hanamura, Ichiro; Kobayashi, Hirofumi; Usuki, Kensuke; Kobayashi, Naoki; Ohyashiki, Kazuma; Utsumi, Takahiko; Kumagai, Kyoya; Maruyama, Dai; Ohmachi, Ken; Matsuno, Yoshihiro; Nakamura, Shigeo; Hotta, Tomomitsu; Tsukasaki, Kunihiro; Nagai, Hirokazu.
Afiliación
  • Ogura M; Department of Hematology, Aichi Sannomaru Clinic, Nagoya, Japan.
  • Yamamoto K; Department of Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
  • Morishima Y; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
  • Wakabayashi M; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
  • Tobinai K; JCOG Data Center, National Cancer Center Hospital, Tokyo, Japan.
  • Ando K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Uike N; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Kurosawa M; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Gomyo H; Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
  • Taniwaki M; Department of Hematology, Hyogo Cancer Center, Akashi, Japan.
  • Nosaka K; Department of Hematology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Tsukamoto N; Department of Hematology, Kumamoto University School of Medicine, Kumamoto, Japan.
  • Shimoyama T; Department of Hematology, Gunma University Hospital, Maebashi, Japan.
  • Fukuhara N; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Tokyo, Japan.
  • Yakushijin Y; Department of Hematology, Tohoku University Hospital, Sendai, Japan.
  • Ohnishi K; First Department of Internal Medicine, Ehime University Graduate School of Medicine, Tohon-shi, Japan.
  • Miyazaki K; Department of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Kameoka Y; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
  • Takayama N; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
  • Hanamura I; Second Department of Internal Medicine, Kyorin University School of Medicine, Mitaka, Japan.
  • Kobayashi H; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
  • Usuki K; Department of Hematology, Saitama Cancer Center Hospital, Saitama, Japan.
  • Kobayashi N; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Ohyashiki K; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Utsumi T; Department of Hematology, Tokyo Medical University, Tokyo, Japan.
  • Kumagai K; Department of Hematology, Shiga General Hospital, Moriyama, Japan.
  • Maruyama D; Department of Hematology, Chiba Cancer Center, Chiba, Japan.
  • Ohmachi K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Matsuno Y; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Nakamura S; Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.
  • Hotta T; Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan.
  • Tsukasaki K; National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Nagai H; Department of Hematology, National Cancer Center East, Kashiwa, Japan.
Cancer Sci ; 114(8): 3461-3465, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37232264
ABSTRACT
Progression-free survival after R-High CHOP/CHASER/LEED with auto-PBSCT in untreated mantle cell lymphoma in JCOG0406 study. A continuous pattern of relapse was observed.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células del Manto Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Cancer Sci Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células del Manto Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Cancer Sci Año: 2023 Tipo del documento: Article País de afiliación: Japón